A REPORT ON Ranbaxy-Daiichi Deal 1/26/2012 Ranbaxy-Daiichi Deal Introduction: Daiichi Sankyo bought Ranbaxy for $4.6 billion in June 2008. This report studies the implications of the merger between Ranbaxy and Daiichi Sankyo‚ from an intellectual property as well as a market point of view. There are many critical events happening in international pharma market including the growing preference for generics‚ increasing dominance of emerging markets such as India‚ fast approaching patent expiry
Premium Generic drug Ranbaxy Laboratories Pharmaceutical industry
Arby’s/Wendy’s Merger Triarc Companies Inc. is a holding company and‚ through one of the subsidiary Arby’s Restaurant Group Inc. is the franchisor of the Arby’s® restaurant system. Arby’s is the second largest restaurant franchising system in the sandwich segment of the quick service restaurant industry. As of June 29‚ 2008‚ there were a total of 3‚719 Arby’s restaurants in the system‚ including 1‚169 Company owned and 2‚550 franchised locations (Triarc‚ 2008). When Dave Thomas‚ founder of
Premium Nelson Peltz Internet Wendy's
THESIS PROPOSAL ON IMPACT OF MERGER AND ACQUISITION IN NEPALESE FINANCIAL SECTOR FOR A BANK SURVIVAL BY SHUSIL RANA MBA ID: 5014/2010 KING’S COLLEGE INTERNATIONAL AMERICAN UNIVERSITY LA‚ USA SUBMITTED TO: RESEACRH COMMITTEE KING’S COLLEGE‚ KATHMANDU NEPAL INTERNATIONAL AMERICAN UNIVERCITY LA‚ USA May 9‚ 2012 Title of the study: "IMPACT OF MERGER AND ACQUISITION IN NEPALESE FINANCIAL SECTOR FOR A BANK SURVIVAL ". INTRODUCTION: Commercial banks have an essential role in the economy.
Premium Bank
MJacob Bliberg (jb3975@stern.nyu.edu) Jasper Buntinx (jasper@buntinx.eu) April 2013 Post-Acquisition Report Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) $6.8Bn acquisition of Cephalon‚ Inc. (NASDAQ: CEPH) – October 14‚ 2011 | Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company which develops‚ produces and markets affordable generic drugs. Teva is the world’s largest generic drug maker‚ with a direct presence in about 60 countries. Teva’s
Premium Generic drug Takeover Pharmaceutical industry
Valuation of Mergers and Acquisitions SUBMITTED BY: DEBAYAN MUKHERJI PGDM ’"2008-2010 ROLL NO: 08PGDM083 INTERNATIONAL MANAGEMENT INSTITUTE‚ NEW DELHI CONTACT NUMBER: 09717443910 EMAIL : debayan.p08@imi.edu Valuation of Mergers and Acquisitions Mergers and acquisitions (more generally‚ takeovers) are an important means through which companies achieve economies of scale‚ face the competition‚ or respond to economic shocks. For example ‚how the $54 billion US chemical major
Premium Discounted cash flow Mergers and acquisitions Stock market
A Project Report for the partial fulfillment of the PGDF Course at SYMBIOSIS CENTRE OF MANAGEMENT and HUMAN RESOURCE DEVELOPMENT Submitted by Jayant Agarwal (PGDF-02) Table of Contents Sl no 1 2 2.1 2.2 3 3.1 3.2 4 5 5.1 5.2 6 7 7.1 7.2 7.3 8 8.1 8.2 8.3 8.4 8.5 8.6 8.7 9 9.1 9.2 10 11 Title Introduction Background of Ranbaxy Brief History Market share of Ranbaxy Background of Daiichi Sankyo Brief History
Premium Pharmaceutical industry Generic drug
MANAGEMENT PROJECT SWOT AND STEEPLED ANALYSIS OF TATA MOTORS BY: Kosuru Sai Malleswar (SC09B093) Dhruti Ranjan Gaan (SC09B017) Kshitiz Sinha (SC09B125) Kumar Harshit (SC09B144) L. Deepak (SC09B074) 1|Page TABLE OF CONTENTS ABSTRACT.................................................................................................................................................. 3 INTRODUCTION ..................................................................................
Premium Tata Motors
Mergers and acquisitions (abbreviated M&A) is an aspect of corporate strategy‚ corporate finance and management dealing with the buying‚ selling‚ dividing and combining of different companies and similar entities that can help an enterprise grow rapidly in its sector or location of origin‚ or a new field or new location‚ without creating a subsidiary‚ other child entity or using a joint venture. The distinction between a "merger" and an "acquisition" has become increasingly blurred in various
Premium Mergers and acquisitions
MARKETING MANAGEMENT REPORT ON TATA INDICA Submitted by: Submitted to: Group-5 (Sec A) Dr. H. Gayathri Aman Srivastav (12005) Gaurav Kumar (12017) Muhammad Rayees. M (12029) Shilpa Giri (12046) Mahajan Swapnil Umashankar (12053) ACKNOWLEDGEMENT We would like to show our greatest appreciation to Dr. H. Gayathri for her tremendous support and help. We feel motivated and encouraged every time we attend
Premium Tata Motors Automotive industry
Sector: IT Consulting & Software CMP: 1288 Rating: BUY Target Price: 1500 Stock Info Investment Period: 15months Introduction: Tata Consultancy Services Limited is an Indian multinational information technology services‚ business solutions and outsourcing Services Company founded by JRD Tata in the year 1968 headquartered in Mumbai. TCS is a subsidiary of the Tata Group. It is one of India’s most valuable companies and is the largest India‐based IT services company by 2012 revenues. It has 183 offices
Premium Financial ratios Generally Accepted Accounting Principles